Herbs (Global Traditional) · Ayurveda
Holy Basil (Ocimum sanctum) (Ocimum sanctum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Holy basil (Ocimum sanctum) contains eugenol, ursolic acid, and rosmarinic acid as primary bioactive compounds that exert adaptogenic effects through modulation of cortisol and inflammatory pathways. This sacred Ayurvedic herb demonstrates antioxidant and antimicrobial properties through free radical scavenging and bacterial membrane disruption.
Holy Basil (Ocimum sanctum L., also known as Ocimum tenuiflorum or Tulsi) is an aromatic perennial shrub native to the Indian subcontinent, belonging to the Lamiaceae family. The herb is sourced from its leaves, stems, inflorescences, and seeds, with extracts typically prepared through solvent extraction (methanol, ethanol, n-hexane) or steam distillation for essential oil production.
The research dossier reveals a significant gap in clinical evidence: no human clinical trials, RCTs, or meta-analyses for Ocimum sanctum were identified. All available data comes from in vitro cell assays and preclinical animal models examining antioxidant, antimicrobial, and antimalarial activities.
No clinically studied human dosage ranges are available. In vitro studies used extract concentrations of 3.98-15.5 µg/mL for antioxidant activity and up to 500 µg/mL for cytotoxicity assays, but these cannot be translated to human doses. Consult a healthcare provider before starting any new supplement.
Holy Basil (Ocimum sanctum) leaves contain moderate macronutrient content per 100g fresh weight: protein ~3-5g, carbohydrates ~5-8g, dietary fiber ~1.5-2g, fat ~0.5-1g, moisture ~85-90g. Key micronutrients include vitamin C (approximately 30-60mg/100g fresh leaves), vitamin A as beta-carotene (~315 µg RAE/100g), calcium (~200-300mg/100g dry weight), iron (~3-5mg/100g dry weight), magnesium (~60-80mg/100g dry weight), and potassium (~300-400mg/100g dry weight). Primary bioactive compounds include: eugenol (the dominant phenylpropanoid, comprising 40-70% of essential oil by GC-MS analysis), ursolic acid (a pentacyclic triterpenoid, ~0.5-1% dry weight), rosmarinic acid (a hydroxycinnamic acid derivative, ~0.2-0.6% dry weight), ocimumosides A and B (glycowithanolides, stress-modulating compounds), linalool (5-15% of essential oil), β-caryophyllene (~3-8% of essential oil), methyl chavicol/estragole (variable, ~1-15% depending on chemotype), orientin and vicenin (flavone C-glycosides), and apigenin and luteolin (free flavones). Essential oil yield is approximately 0.4-0.8% of fresh leaf weight. Bioavailability notes: eugenol exhibits good oral bioavailability with rapid absorption; rosmarinic acid has moderate bioavailability (~1-5% absorbed intact) with gut microbiota converting remainder to smaller phenolic acids; fat-soluble triterpenoids like ursolic acid have low aqueous solubility but absorption enhanced by lipid co-ingestion; fresh leaf consumption or aqueous extracts preserve heat-labile vitamin C better than dried preparations; three recognized chemotypes exist (eugenol-rich, methyl eugenol-rich, and morphotype-III), significantly affecting bioactive compound concentrations across commercial sources.
Holy basil's eugenol and ursolic acid compounds modulate the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol production and normalizing stress responses. The herb's phenolic compounds like rosmarinic acid scavenge free radicals by donating electrons to reactive oxygen species, while eugenol disrupts bacterial cell membranes through lipid peroxidation. These mechanisms collectively support adaptogenic activity and cellular protection against oxidative stress.
Current evidence for holy basil consists primarily of in vitro studies demonstrating antioxidant activity against DPPH, superoxide, and hydroxyl radicals with IC50 values typically ranging from 25-150 μg/mL depending on extraction method. Antimicrobial studies using resazurin microtiter assays show inhibitory activity against various bacterial pathogens with minimum inhibitory concentrations of 50-200 μg/mL. Human clinical trials are limited, with small pilot studies (n=20-40) suggesting stress-reducing effects at doses of 300-600mg daily, though larger randomized controlled trials are needed. The preliminary nature of current evidence limits definitive therapeutic claims.
Holy basil is generally well-tolerated in traditional use, though it may cause mild gastrointestinal upset, drowsiness, or hypoglycemia in sensitive individuals. The herb may interact with anticoagulant medications due to eugenol's blood-thinning properties and could potentiate hypoglycemic effects of diabetes medications. Pregnant and breastfeeding women should avoid holy basil as it may affect uterine contractions and hormone levels. Individuals scheduled for surgery should discontinue use 2 weeks prior due to potential bleeding risk interactions with anesthesia.
